Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
Respiratory syncytial virus (RSV) is responsible for a significant proportion of global morbidity and mortality affecting young children and older adults. In the aftermath of formalin-inactivated RSV vaccine development, the effort to develop an immunizing agent was carefully guided by epidemiologic...
Main Authors: | Xanthippi Topalidou, Alexis M. Kalergis, Georgios Papazisis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/12/10/1259 |
Similar Items
-
Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States
by: Mark H. Rozenbaum, et al.
Published: (2023-01-01) -
Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly Population
by: Laura M. Stephens, et al.
Published: (2021-06-01) -
Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology Approach
by: Muhammad Tahir ul Qamar, et al.
Published: (2020-06-01) -
The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis
by: Daisuke Kurai, et al.
Published: (2024-12-01) -
Mutation of Respiratory Syncytial Virus G Protein’s CX3C Motif Attenuates Infection in Cotton Rats and Primary Human Airway Epithelial Cells
by: Binh Ha, et al.
Published: (2019-07-01)